Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06232590 · ClinicalTrials.gov registry record · NA
Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types
A NA study, sponsored by CooperVision International Limited (CVIL).
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06232590: Completed NA study, sponsored by CooperVision International Limited (CVIL).
NCT06232590 is a NA study that has completed, run by CooperVision International Limited (CVIL). The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06232590, a NA study, has completed, sponsored by CooperVision International Limited (CVIL).
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
To evaluate and compare the performance of two monthly replacement multifocal contact lenses in existing wearers.
Primary Outcome
Subjective rating collected in office using a 0-100 scale, where 0=Very difficult and 100=Very easy. The participant rated the study lens considering a typical day in the last 1 month of wear.
Interventions
- DEVICE Control Lens (comfilcon A)
- DEVICE Test Lens (lehfilcon A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-02-23 |
| Est. Completion | 2024-07-09 |
| Phase | NA |
What the finished NCT06232590 record still lists
NCT06232590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Lens (comfilcon A) is the first listed.
NCT06232590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06232590 about?
NCT06232590 is a clinical study titled "Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types". To evaluate and compare the performance of two monthly replacement multifocal contact lenses in existing wearers.
What is the current status of trial NCT06232590?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2024-02-23. Estimated completion is 2024-07-09.
What interventions are being tested in trial NCT06232590?
The interventions under investigation include: Control Lens (comfilcon A) (DEVICE), Test Lens (lehfilcon A) (DEVICE).
Who is sponsoring clinical trial NCT06232590?
This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06232590's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI